Liver Function's impact on experimental brain drug tested
NCT ID NCT05731895
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the experimental drug iclepertin (BI 425809) is processed in people with and without liver problems. 29 adults aged 18-79 took a single dose of the drug. Researchers measured drug levels in the blood and monitored safety to see if liver impairment changes how the drug works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, 24105, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver function and drug dosing: a closer look at ulonivirine
- Liver function may change how mavorixafor works in the body
- New cholesterol drug tested in liver patients
- Liver function study tests drug processing in 29 volunteers
- New drug safety check for liver patients
- Liver scan may predict deadly failure after big operations